(Q38472134)

3 September 2017

title

REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma (English)

1 reference

3 September 2017

0 references

1 reference

12

Masaki Mori

1 reference

3 September 2017

13

Yuichiro Doki

1 reference

3 September 2017

11

Yukinori Kurokawa

1 reference

3 September 2017

7

Shuji Takiguchi

1 reference

3 September 2017

8

Kiyokazu Nakajima

1 reference

3 September 2017

9

Hiroshi Miyata

1 reference

3 September 2017

Jeong-Ho Moon

1

1 reference

3 September 2017

Yoshiyuki Fujiwara

2

1 reference

3 September 2017

Yurika Nakamura

3

1 reference

3 September 2017

Kaoru Okada

4

1 reference

3 September 2017

Hiroyuki Hanada

5

1 reference

3 September 2017

Chohei Sakakura

6

1 reference

3 September 2017

Makoto Yamasaki

10

1 reference

3 September 2017

publication date

20 July 2011

1 reference

Journal of Surgical Oncology

3 September 2017

published in

1 reference

3 September 2017

volume

105

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

189-194

1 reference

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

3 September 2017

cites work

1 reference

Global cancer statistics, 2002

21 January 2018

1 reference

Adenocarcinoma of the stomach: Review of 1,497 cases

21 January 2018

1 reference

Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV.

21 January 2018

1 reference

Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma

21 January 2018

1 reference

Reg IV: a promising marker of hormone refractory metastatic prostate cancer

21 January 2018

1 reference

Reg IV, a new member of the regenerating gene family, is overexpressed in colorectal carcinomas

21 January 2018

1 reference

Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4.

21 January 2018

1 reference

Reg IV expression and clinicopathologic features of gallbladder carcinoma.

21 January 2018

1 reference

Overexpression of Reg IV in colorectal adenoma

21 January 2018

1 reference

RegIV potentiates colorectal carcinoma cell migration and invasion via its CRD domain

21 January 2018

1 reference

Reg IV activates the epidermal growth factor receptor/Akt/AP-1 signaling pathway in colon adenocarcinomas

21 January 2018

1 reference

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy

21 January 2018

1 reference

Reg IV enhances peritoneal metastasis in gastric carcinomas

21 January 2018

1 reference

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

21 January 2018

1 reference

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Intercalation activating fluorescence DNA probe and its application to homogeneous quantification of a target sequence by isothermal sequence amplification in a closed vessel.

21 January 2018

1 reference

Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.

21 January 2018

1 reference

Rapid genetic diagnosis with the transcription-reverse transcription concerted reaction system for cancer micrometastasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JSO.22021

1 reference

3 September 2017

1 reference